Avanza Fonder Ab Regeneron Pharmaceuticals, Inc. Transaction History
Avanza Fonder Ab
- $3.05 Trillion
- Q1 2025
A detailed history of Avanza Fonder Ab transactions in Regeneron Pharmaceuticals, Inc. stock. As of the latest transaction made, Avanza Fonder Ab holds 8,899 shares of REGN stock, worth $5.21 Million. This represents 0.18% of its overall portfolio holdings.
Number of Shares
8,899
Previous 10,408
14.5%
Holding current value
$5.21 Million
Previous $7.41 Billion
24.91%
% of portfolio
0.18%
Previous 0.22%
Shares
2 transactions
Others Institutions Holding REGN
# of Institutions
1,467Shares Held
85.9MCall Options Held
1.06MPut Options Held
1.36M-
Vanguard Group Inc Valley Forge, PA9.41MShares$5.5 Billion0.11% of portfolio
-
Black Rock Inc. New York, NY8.45MShares$4.94 Billion0.2% of portfolio
-
Jpmorgan Chase & CO New York, NY5.66MShares$3.31 Billion0.28% of portfolio
-
State Street Corp Boston, MA4.79MShares$2.8 Billion0.13% of portfolio
-
Capital International Investors Los Angeles, CA3.99MShares$2.33 Billion0.52% of portfolio
About REGENERON PHARMACEUTICALS, INC.
- Ticker REGN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 107,190,000
- Market Cap $62.7B
- Description
- Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...